MCUJF (Medicure) ROE % Adjusted to Book Value : 25.63% (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Medicure ROE % Adjusted to Book Value?

Medicure's ROE % for the quarter that ended in Sep. 2024 was 13.84%. Medicure's PB Ratio for the quarter that ended in Sep. 2024 was 0.54. Medicure's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 25.63%.

Medicure ROE % Adjusted to Book Value Historical Data

The historical data trend for Medicure's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure ROE % Adjusted to Book Value Chart

Medicure Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-21.26

-47.17

-7.44

12.70

-8.25

Medicure Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.15	-54.16	1.71	-38.35	25.63

Competitive Comparison of Medicure's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medicure's ROE % Adjusted to Book Value falls into.

Medicure ROE % Adjusted to Book Value Calculation

Medicure's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-4.54%	/	0.55
	=	-8.25%

Medicure's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.84%	/	0.54
	=	25.63%

Medicure ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medicure's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (OTCPK:MCUJF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

NGQ1:Germany MPH:Canada

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.